NVO
Novo Nordisk A/S
$60.71
-$0.69(-1.12%)
48
Overall
60
Value
36
Tech
--
Quality
Market Cap
$255.40B
Volume
10.69M
52W Range
$45.05 - $127.61
Target Price
$65.88
EPS Estimates Overview
| Current Quarter | $0.95 | Next Quarter | $0.99 |
| Current Year | $3.85 | Next Year | $4.07 |
| QoQ Growth | +4.2% | YoY Growth | +5.7% |
| 3Y EPS CAGR | +29.7% | Target Price | $65.88 |
| Consensus | Buy | Upside | +8.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVO | $60.71 | -1.1% | 10.69M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |